Skip to content
HowShorted

Cidara Therapeutics, Inc. short interest in 2020

In 2020, Cidara Therapeutics, Inc.'s disclosed short interest ran from 3.73% of shares outstanding on 15 Jan 2020 to 3.58% on 31 Dec 2020, a change of -0.15 percentage points. The year's high was 6.70% on 14 Feb 2020 and its low 3.56% on 13 Nov 2020, averaging 4.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.95 days on 30 Oct 2020. Full history: Cidara Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Cidara Therapeutics, Inc. in 2020

2020 in figures

Start of year
3.73% (15 Jan 2020)
End of year
3.58% (31 Dec 2020)
Change
-0.15 pp
High
6.70% (14 Feb 2020)
Low
3.56% (13 Nov 2020)
Average
4.81%
Highest days to cover
23.95 (30 Oct 2020)
SEC filings marked
8

Every report in 2020

Cidara Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20203.73%4.01
31 Jan 20205.63%2.80
14 Feb 20206.70%8.16
28 Feb 20205.90%8.41
13 Mar 20206.29%4.1310-K filed, results (8-K)
31 Mar 20205.62%10.03
15 Apr 20205.28%6.20
30 Apr 20203.96%9.95
15 May 20203.82%5.8310-Q filed, results (8-K)
29 May 20203.86%6.64
15 Jun 20203.85%10.05
30 Jun 20205.42%3.63
15 Jul 20205.98%11.90
31 Jul 20205.98%14.07
14 Aug 20205.10%12.0110-Q filed, results (8-K)
31 Aug 20205.07%22.16
15 Sep 20204.86%7.56
30 Sep 20204.87%9.62
15 Oct 20204.54%20.23
30 Oct 20204.48%23.95
13 Nov 20203.56%2.9310-Q filed, results (8-K)
30 Nov 20203.57%7.62
15 Dec 20203.67%4.85
31 Dec 20203.58%2.76

See also: Cidara Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.